DLRHX
Price
$24.35
Change
-$0.46 (-1.85%)
Updated
Sep 12 closing price
Net Assets
652.03M
FSPHX
Price
$26.90
Change
-$0.35 (-1.28%)
Updated
Sep 12 closing price
Net Assets
5.88B
Interact to see
Advertisement

DLRHX vs FSPHX

Header iconDLRHX vs FSPHX Comparison
Open Charts DLRHX vs FSPHXBanner chart's image
Macquarie Healthcare R
Price$24.35
Change-$0.46 (-1.85%)
VolumeN/A
Net Assets652.03M
Fidelity Select Health Care
Price$26.90
Change-$0.35 (-1.28%)
VolumeN/A
Net Assets5.88B
DLRHX vs FSPHX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DLRHX vs. FSPHX commentary
Sep 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DLRHX is a Hold and FSPHX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSPHX has more cash in the bank: 5.88B vs. DLRHX (652M). FSPHX pays higher dividends than DLRHX: FSPHX (0.02) vs DLRHX (0.00). DLRHX was incepted earlier than FSPHX: DLRHX (16 years) vs FSPHX (44 years). DLRHX (1.50) is less costly to investors than FSPHX (0.63). FSPHX is a more actively managed with annual turnover of: 40.00 vs. DLRHX (5.00). DLRHX (0) and FSPHX (0) have matching initial minimum investment requirements. FSPHX annual gain was more profitable for investors over the last year : -15.15 vs. DLRHX (-16.09). DLRHX return over 5 years is better than : -7.72 vs. FSPHX (-11.50).
DLRHXFSPHXDLRHX / FSPHX
Total Expense Ratio1.460.63232%
Annual Report Gross Expense Ratio1.500.63238%
Fund Existence16 years44 years-
Gain YTD5.732-1.284-446%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets652M5.88B11%
Annual Yield % from dividends0.000.02-
Returns for 1 year-16.09-15.15106%
Returns for 3 years-0.70-1.9536%
Returns for 5 years-7.72-11.5067%
Returns for 10 years23.2419.31120%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BCEMX27.74N/A
N/A
Boston Common ESG Impact Em Mkts
KLGNX53.56-0.04
-0.07%
NYLI WMC Growth Investor Class
JUEQX27.75-0.03
-0.11%
JPMorgan US Equity R4
ARSMX9.99-0.13
-1.28%
AMG River Road Small-Mid Cap Value N
FHCCX39.19-0.52
-1.31%
Fidelity Advisor Health Care C